Influence of genetic factors in the modulation of postprandial lipemia

Atherosclerosis Supplements

Volumn 9, Issue 2, 2008, Pages 49-55

  Perez Martinez, Pablo ^a,b   Lopez Miranda, Jose ^b   Perez Jimenez, Francisco ^b   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Fat overload; Gene diet interaction; Polymorphism; Postprandial lipemia

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHYLOMICRON REMNANT; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; LIVER TRIACYLGLYCEROL LIPASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN FABP2; SCAVENGER RECEPTOR B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALIMENTARY LIPEMIA; APOA1 GENE; APOA2 GENE; APOA5 GENE; APOB GENE; APOC1 GENE; APOC3 GENE; APOE GENE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; FABP2 GENE; FAT INTAKE; FATP1 GENE; FOOD INTAKE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HL GENE; HUMAN; HYPERLIPIDEMIA; LIPID HYDROLYSIS; LIPID METABOLISM; LIPOPROTEIN SYNTHESIS; LPL GENE; MTP GENE; PLIN GENE; POSTPRANDIAL STATE; PPARG GENE; PRIORITY JOURNAL; REVIEW; SCARB1 GENE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS; CHYLOMICRONS; DYSLIPIDEMIAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD;

EID: 50849100116     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2008.05.005     Document Type: Review

References (54)

1. Calabresi L., Cassinotti M., Gianfranceschi G., et al. Increased postprandial lipemia in Apo A-IMilano carriers. Arterioscler Thromb 13 (1993) 521-528
2. Marin C., Lopez-Miranda J., Gomez P., et al. Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism. Am J Clin Nutr 76 (2002) 319-325
3. Boisfer E., Lambert G., Atger V., et al. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis. J Biol Chem 274 (1999) 11564-11572
4. van't Hooft F.M., Ruotolo G., Boquist S., et al. Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104 (2001) 1223-1228
5. Goldberg I.J., Scheraldi C.A., Yacoub L.K., et al. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 265 (1990) 4266-4272
6. Ostos M.A., Lopez-Miranda J., Marin C., et al. The apolipoprotein A-IV-360 His polymorphism determines the dietary fat clearance in normal subjects. Atherosclerosis 153 (2000) 209-217
7. Ostos M.A., Lopez-Miranda J., Ordovas J.M., et al. Dietary fat clearance is modulated by genetic variation in apolipoprotein A-IV gene locus. J Lipid Res 39 (1998) 2493-2500
8. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294 (2001) 169-173
9. Martin S., Nicaud V., Humphries E., et al. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Bochim Biophys Acta 1637 (2003) 217-225
10. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/AV gene cluster in determining plasma triglycerides. Hum Mol Genet 11 (2002) 3039-3046
11. Aouizerat B.E., Kulkarni M., Heilbron D., et al. Genetic analysis of a polymorphism in the human apolipoprotein A-V gene: effect on plasma lipids. J Lipid Res 44 (2003) 1167-1173
12. Moreno R., Perez-Jimenez F., Marin C., et al. A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T > C modulates postprandial lipoprotein metabolism. Atherosclerosis 189 (2006) 163-168
13. Austin M.A., Talmud P.J., Farin F.M., et al. Association of apolipoprotein A5 variants with LDL particle size and triacylglycerol in Japanese Americans. Biochim Biophys Acta 1688 (2004) 1-9
14. Szalai C., Keszei M., Duba J., et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173 (2004) 109-114
15. Dallongevillea J., Cottela D., Montayea M., et al. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 106 (2006) 152-156
16. Moreno R., Perez-Jimenez F., Marin C., et al. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population. J Clin Endocrinol Metab 92 (2007) 2280-2285
17. Carlsson P., Darnfors C., Olofsson S.O., et al. Analysis of the human apolipoprotein B gene; complete structure of the B-74 region. Gene 49 (1986) 29-51
18. Lopez-Miranda J., Ordovas J.M., Ostos M.A., et al. Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 17 (1997) 1765-1773
19. Boerwinkle E., and Chan L. A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction. Nucleic Acids Res 17 (1989) 4003
20. Perez-Martinez P., Perez-Jimenez F., Ordovas J.M., et al. Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population. Lipids 42 (2007) 143-150
21. Waterworth D.M., Hubacek J.A., Pitha J., et al. Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster. J Lipid Res 41 (2000) 1103-1109
22. Dammerman M., Sandkuijl L.A., Halaas J.L., et al. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90 (1993) 4562-4566
23. Woo S.K., and Kang H.S. The apolipoprotein CIII T2854G variants are associated with postprandial triacylglycerol concentrations in normolipidemic Korean men. J Hum Genet 48 (2003) 551-555
24. Miettinen T.A., Gylling H., Vanhanen H., et al. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 12 (1992) 1044-1052
25. Moreno J.A., Lopez-Miranda J., and Perez-Jimenez F. Influence of genetic and environmental factors on lipid metabolism and cardiovascular risk associated with the apoE gene. Med Clin (Barc) 127 (2006) 343-351
26. Sing C.F., and Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37 (1985) 268-285
27. Cardona F., Morcillo S., Gonzalo-Marin M., et al. The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 2972-2975
28. Moreno J.A., Lopez-Miranda J., Marin C., et al. The influence of the apolipoprotein E gene promoter (219G/T) polymorphism on postprandial lipoprotein metabolism in young normolipemic males. J Lipid Res 44 (2003) 2059-2064
29. Agren J.J., Valve R., Vidgren H., et al. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 18 (1998) 1606-1610
30. Tahvanainen E., Molin M., Vainio S., et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 152 (2000) 317-325
31. Dworatzek P.D., Hegele R.A., and Wolever T.M. Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. Am J Clin Nutr 79 (2004) 1110-1117
32. Gertow K., Skoglund-Andersson C., Eriksson P., et al. A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution. Atherosclerosis 167 (2003) 265-273
33. Wilson D.E., Emi M., Iverius P.H., et al. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 86 (1990) 735-750
34. Bijvoet S., Gagne S.E., Moorjani S., et al. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res 37 (1996) 640-650
35. Talmud P.J., Hall S., Holleran S., et al. LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. J Lipid Res 39 (1998) 1189-1196
36. Gerdes C., Fisher R.M., Nicaud V., et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation 96 (1997) 733-740
37. Lopez-Miranda J., Cruz G., Gomez P., et al. The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab 89 (2004) 4721-4728
38. Jansen H., Verhoeven A.J., Weeks L., et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 11 (1997) 2837-2842
39. Jansen H., Chu G., Ehnholm C., et al. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 19 (1999) 303-308
40. Gomez P., Miranda J.L., Marin C., et al. Influence of the -514C/T polymorphism in the promoter of the hepatic lipase gene on postprandial lipoprotein metabolism. Atherosclerosis 174 (2004) 73-79
41. Karpe F., Lundahl B., Ehrenborg E., et al. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 18 (1998) 756-761
42. Phillips C., Mullan K., Owens D., et al. Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes. QJM 97 (2004) 211-218
43. Acton S.L., Scherer P.E., Lodish H.F., et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 269 (1994) 21003-21009
44. Acton S., Rigotti A., Landschultz K.T., et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
45. Hauser H., Dyer J.H., Nandy A., et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 37 (1998) 17843-17850
46. Cao G., Garcia C.K., Wyne K.L., et al. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272 (1997) 33068-33076
47. Perez-Martinez P., Lopez-Miranda J., Ordovas J.M., et al. Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus. J Mol Endocrinol 32 (2004) 237-245
48. Tanaka T., Delgado-Lista J., Lopez-Miranda J., et al. Scavenger receptor class B Type I (SCARB1) c 1119C > T polymorphism affects postprandial triglyceride metabolism in men. J Nutr 137 3 (2007) 578-582
49. Cardona F., Morcillo S., Gonzalo-Marin M., et al. Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome. Clin Chem 52 10 (2006) 1920-1925
50. Brasaemle D.L., Rubin B., Harten I.A., et al. Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 275 (2000) 38486-38493
51. Mori Y., Otabe S., Dina C., et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 51 (2002) 1247-1255
52. Perez-Martinez P., Yiannakouris N., Lopez-Miranda J., et al. Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations. Am J Clin Nutr 87 3 (2008) 744-752
53. Levy E., Spahis S., Sinnett D., et al. Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol 18 (2007) 310-318
54. Chan DC, Watts GF, Wang J, Hegele RA, van Bockxmeer FM, Barrett PH. Variation in Niemann-Pick C1-Like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men. Clin Endocrinol 2007 (November 19) [Epub ahead of publication].